The Zenflow Spring System Safety and Performance Study (ZEST CAN)

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 9, 2021

Primary Completion Date

December 1, 2025

Study Completion Date

January 1, 2026

Conditions
Benign Prostatic Hyperplasia
Interventions
DEVICE

Zenflow Spring System

The Zenflow Spring is a nitinol urethral implant for the treatment of Lower Urinary Tract Symptoms (LUTS) that arise due to bladder outlet obstruction (BOO), secondary to the presence of Benign Prostatic Hypertrophy (BPH). The device is intended to be a permanent implant however it may be removed if necessary.

Trial Locations (2)

M5T 2S8

RECRUITING

Toronto Western Hospital, Toronto

H9R 5K3

RECRUITING

Groupe Sante Brunswick, Pointe-Claire

All Listed Sponsors
lead

Zenflow, Inc.

INDUSTRY

NCT04309695 - The Zenflow Spring System Safety and Performance Study (ZEST CAN) | Biotech Hunter | Biotech Hunter